The US Food and Drug Administration (FDA) has issued a warning regarding the use of select Magellan Diagnostics’ lead tests.

The FDA and Centers for Disease Control and Prevention (CDC) said that the results from LeadCare, LeadCare II, LeadCare Plus and LeadCare Ultra tests may be inaccurate in some American children and adults.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

CDC recommended that children aged less than six years, pregnant women and nursing mothers should seek a health professional for a retest on lead exposure.

FDA Center for Devices and Radiological Health director Jeffrey Shuren said: “The FDA is deeply concerned by this situation and is warning laboratories and healthcare professionals that they should not use any Magellan Diagnostics’ lead tests with blood drawn from a vein.

“The agency is aggressively investigating this complicated issue to determine the cause of the inaccurate results and working with the CDC and other public health partners to address the problem as quickly as possible.”

See Also:

The available data indicated that the lead tests may present results lower than the original level of lead present.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The agency is aggressively investigating this complicated issue to determine the cause of the inaccurate results and working with the CDC and other public health partners to address the problem as quickly as possible."

According to FDA, the problem with the results may date back to 2014. Currently, the tests are being used on blood from a finger or heel stick.

CDC National Center for Environmental Health director Patrick Breysse said: “While most children likely received an accurate test result, it is important to identify those whose exposure was missed or underestimated so that they can receive proper care.

“For this reason, because every child’s health is important, the CDC recommends that those at greatest risk be retested.”

The retests are recommended only if the test has been performed with blood from a vein using any Magellan Diagnostics’ LeadCare Systems and obtained a result less than 10µg/dL.

Image: FDA warns about the risk of inaccurate blood test results by using certain lead tests. Photo: courtesy of meepoohyaphoto via FreeDigitalPhotos.net.